{
    "2014-12-09": [
        "RT @FiercePharma: UPDATED with comments from $MRK: Did Merck pay $3B too much for Cubist? Weighing the impact of Cubicin patent loss",
        "Small-cap stocks breaking 52-wk high prices $SGEN $MRK $BRE $CAG #personalfinance",
        "Merck Bets $9.5 Billion On Cubist's War On Superbugs #IBDNews @IBDinvestors $MRK $CBST $HSP $GSK",
        "cowen legal experts do not believe $CBST appeal will be successful - $MRK may be able to preserve EPS via SG&A cuts",
        "$CBST says $MRK deal unaffected by Hospira decision, plans to appeal judgement"
    ]
}